Home > Insider Trading > Filing (0001104659-23-123734)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819576	Liquidia Corp	LQDA	Pharmaceutical Preparations (2834)	851710962

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1832592	Scott Moomaw	419 Davis Drive, Suite 100 Morrisville NC 27560	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-30	1,875	$0.00	107,279	No	4	M	Direct
Common Stock	Disposition	2023-11-30	542	$7.28	106,737	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2023-11-30	1,875	$0.00	1,875	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,875			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
On January 16, 2022, the Reporting Person was granted 30,000 RSUs with 25% vesting on February 28, 2023, with the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 13,125 have vested through November 30, 2023.
Includes (i) 83,333 RSUs granted to the Reporting Person on January 11, 2023, none of which have vested as of the date of this Form 4 and (ii) 6,530 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
These shares were sold to cover taxes associated with the settlement of RSUs.
Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2022.